T-cell effector pathways in allergic diseases: Transcriptional mechanisms and therapeutic targets

  • Chatila T
  • Li N
  • Garcia-Lloret M
 et al. 
  • 46


    Mendeley users who have this article in their library.
  • 44


    Citations of this article.


Originally interpreted within the framework of a binary TH1/TH2 paradigm, our knowledge of the pathogenesis of atopic diseases has broadened to incorporate the contribution of T regulatory cells and the newly described proinflammatory TH17 cell lineage. The commitment of peripheral T-cell clones to undergo differentiation into one of those lineages is shaped by self-reinforcing transcriptional circuitries that center on key transcriptional regulators: T-box expressed in T cells (TH1), GATA-3 (TH2), forkhead box p3 (T regulatory cells), and retinoid-related orphan receptor γτ/retinoid-related orphan receptor α (TH17). These circuits function both to establish the respective lineage phenotype and to enable epigenetic changes that maintain those phenotypes long-term. This evolving view of how signaling and transcriptional networks generate effector T-cell responses suggests novel therapeutic approaches to reprogram effector T-cell lineage commitment in allergic diseases in favor of tolerance induction. © 2008 American Academy of Allergy, Asthma & Immunology.

Author-supplied keywords

  • Foxp3
  • GATA-3
  • Nrf2
  • RORγτ
  • T-bet
  • T-cell differentiation
  • TH1
  • TH17
  • TH2
  • Transcriptional regulation
  • Treg
  • asthma
  • atopic disease
  • oxidative stress
  • therapeutic strategies

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free